NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

PNC Infratech Sees Gradual Recovery Amid Positive Brokerage Outlook

Domestic brokerage firms have maintained a positive outlook on PNC Infratech following the company's March quarter performance, expecting a gradual recovery in revenues over FY27 and FY28. This recovery is supported by a healthy executable order book, improving order inflows, and a ramp-up in execution across key projects.

Analysts expect the stock to rise up to ₹315 apiece, implying a potential upside of nearly 46% from Friday's closing price of ₹215. The company is well-positioned for a recovery cycle as execution intensity improves and newer business verticals scale up.

HDFC Securities maintained its 'Buy' rating with a target price of ₹304, highlighting expectations of a recovery in execution and order inflows during FY27. The brokerage noted that PNC's order book stood at around ₹180 billion as of March 2026, providing strong revenue visibility. New business segments such as renewables and mining are expected to drive future order inflows, while cash inflows from asset monetisation to Vertis contributed to PNC's healthy cash buffer.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Brokerage FirmRatingTarget Price
Ambit CapitalBuy₹276
ICICI SecuritiesBuy₹290
HDFC SecuritiesBuy₹304
Nuvama Institutional EquitiesHold₹235

Other domestic brokerages, including Ambit Capital and ICICI Securities, have also maintained or upgraded their ratings on PNC Infratech. Ambit Capital retained its 'Buy' rating with a target price of ₹276, noting that the company has been able to maintain EBITDA margins despite weak execution trends over the last few quarters. ICICI Securities upgraded the stock to 'Buy' with a target price of ₹290, citing improving execution visibility and a strong executable order book.

Meanwhile, Nuvama Institutional Equities maintained a 'Hold' rating with a target price of ₹235, while acknowledging improving segmental diversification in the company's order book growth. The brokerage noted that management is targeting a higher share of non-road projects in future order inflows, with 30-35% of upcoming orders expected to come from segments such as solar, battery energy storage systems, and urban development projects.

Brokerages broadly expect order inflow momentum and execution recovery to remain the key monitorables for the company over the next few quarters.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

The company's shares staged a strong recovery in April, surging 33% after ending three straight months in the red. Although the stock recovered sharply, it still remains nearly 63% below its record high of ₹574.80, touched in May 2024. The stock witnessed prolonged selling pressure between June 2024 and March 2026, losing a cumulative 66% during the period.

Investor Takeaway

Investors may consider a buy call for PNC Infratech based on its potential recovery and order inflows.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.